Elysium Therapeutics
Danville, US · Founded 2013
Biotech
Founders & leadership
KE
Kathy E. LaPorteDirector
AG
Alex Gregory SturmerExecutive Officer, Director
BE
Bob E. RappaportDirector
TE
Thomas E. JenkinsExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$2.2MraisedOct 2022 · 30 investors · Biotechnology
Rule 506(b)$215KraisedMar 2019 · 4 investors · Biotechnology
Rule 506(b)$932KraisedSep 2018 · 21 investors · Other Health Care
Rule 506(b)$651.8KraisedDec 2017 · 14 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.